Topic Highlight
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Feb 7, 2008; 14(5): 685-692
Published online Feb 7, 2008. doi: 10.3748/wjg.14.685
Figure 8
Figure 8 Adoptive immunotherapy in HCC. Autologous lymphocytes activated in vitro with recombinant interleukin-2 and infused five times during the first month. Adoptive immunotherapy reduces recurrence and improves recurrence-free survival after surgery for HCC. Takayama et al. Lancet 2000.